ResMed Inc. — Operating Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8910237d-456f-4f22-9b08-a51982947f23/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2026 | $1.9B | 2025-07-01 – 2026-06-30 | evidence 0000943819-26-000047 |
| FY 2025 | $1.7B | 2024-07-01 – 2025-06-30 | evidence 0000943819-25-000035 |
| FY 2024 | $1.3B | 2023-07-01 – 2024-06-30 | evidence 0000943819-24-000013 |
| FY 2023 | $1.1B | 2022-07-01 – 2023-06-30 | evidence 0000943819-23-000011 |
| FY 2022 | $1.0B | 2021-07-01 – 2022-06-30 | evidence 0000943819-22-000010 |
| FY 2021 | $903.7M | 2020-07-01 – 2021-06-30 | evidence 0000943819-21-000017 |
| FY 2020 | $809.7M | 2019-07-01 – 2020-06-30 | evidence 0000943819-20-000013 |
| FY 2019 | $579.3M | 2018-07-01 – 2019-06-30 | evidence 0000943819-19-000017 |
| FY 2018 | $541.8M | 2017-07-01 – 2018-06-30 | evidence 0000943819-18-000013 |
| FY 2017 | $425.8M | 2016-07-01 – 2017-06-30 | evidence 0001193125-17-248016 |
| FY 2016 | $429.0M | 2015-07-01 – 2016-06-30 | evidence 0001193125-16-673607 |
| FY 2015 | $409.2M | 2014-07-01 – 2015-06-30 | evidence 0001193125-15-281887 |
| FY 2014 | $405.1M | 2013-07-01 – 2014-06-30 | evidence 0001193125-14-301852 |
| FY 2013 | $354.8M | 2012-07-01 – 2013-06-30 | evidence 0001193125-13-331415 |
| FY 2012 | $294.4M | 2011-07-01 – 2012-06-30 | evidence 0001193125-12-353206 |
| FY 2011 | $266.9M | 2010-07-01 – 2011-06-30 | evidence 0001193125-11-224622 |
| FY 2010 | $240.4M | 2009-07-01 – 2010-06-30 | evidence 0001193125-11-224622 |
| FY 2009 | $190.3M | 2008-07-01 – 2009-06-30 | evidence 0001193125-11-224622 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).